Literature DB >> 3573901

Major complications following tracheoesophageal puncture for voice rehabilitation.

J C Andrews, R A Mickel, D G Hanson, G P Monahan, P H Ward.   

Abstract

The successful use of the tracheoesophageal voice prosthesis for speech rehabilitation of the total laryngectomy patient has lead to common application of this device. Although the creation of a tracheoesophageal fistula is a simple procedure, it is not without complications. A review of 104 patients who underwent this procedure indicated a complication rate of 25%. Complications were related primarily to the fistula and included migration and progressive enlargement of the puncture, persistent or recurring infection of the fistula site, aspiration pneumonia, and death. Other problems included aspiration of the prosthesis, vertebral osteomyelitis, and tracheal stomal and esophageal stenosis. Many of these patients required hospitalization, intravenous antibiotics, and major surgical procedures to treat these complications. Guidelines for early identification and management of these problems as well as methods to prevent complications are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3573901     DOI: 10.1288/00005537-198705000-00005

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  24 in total

1.  [Perforation of the esophagus with a mediastinal abscess].

Authors:  K Scheuermann; K-W Delank
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

2.  [Solving problems after rehabilitation with voice prostheses : Two rare cases of fistula-related complications].

Authors:  K J Lorenz; S Nolte
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

3.  Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.

Authors:  Sarah A Gitomer; Katherine A Hutcheson; Brandon L Christianson; Madeleine B Samuelson; Denise A Barringer; Dianna B Roberts; Amy C Hessel; Randal S Weber; Jan S Lewin; Mark E Zafereo
Journal:  Head Neck       Date:  2016-07-09       Impact factor: 3.147

4.  A Novel Obturator Device for Management of Dilated Trachea-esophageal Puncture Tract Fistulas.

Authors:  Pankaj Chaturvedi; Prashant Pawar; Kanchan Dholam; Deepa Nair; Sudhir Nair; Sourav Datta; Sagar Shridhar Vaishampayan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-24

Review 5.  The development and treatment of periprosthetic leakage after prosthetic voice restoration: a literature review and personal experience. Part II: conservative and surgical management.

Authors:  Kai J Lorenz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-18       Impact factor: 2.503

Review 6.  The development and treatment of periprosthetic leakage after prosthetic voice restoration. A literature review and personal experience part I: the development of periprosthetic leakage.

Authors:  Kai J Lorenz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-18       Impact factor: 2.503

7.  Cervical Stabilization in Patients with Instability Resulting from Osteoradionecrosis with Subsequent Spondylodiscitis After Radiotherapeutic Treatment for Head- and Neck Carcinoma.

Authors:  L L Eenhuis; H P Bijl; J M A Kuijlen; J Wedman
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-12-08

8.  The Indian experience with immediate tracheoesophageal puncture for voice restoration.

Authors:  A R Mehta; S Sarkar; S A Mehta; G K Bachher
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  Tracheoesophageal fistula length decreases over time.

Authors:  Nancy Jiang; Ann Kearney; Edward J Damrose
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-07       Impact factor: 2.503

10.  Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence?

Authors:  Konstantinos D Markou; Konstantinos C Vlachtsis; Angelos C Nikolaou; Dimitrios G Petridis; Athanasios I Kouloulas; Ioannis C Daniilidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-10       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.